MIR4747

Across TCGA pan-cancer cohorts, MIR4747 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR4747 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MIR4747 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4747 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LGG show a favorable association.

THCA, BLCA, and ESCA are the cancer types where MIR4747 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.698	0.976	<.001	108	view →
BLCA	DFS	Tertile	All	0.121	0.594	.009	63	view →
ESCA	DFS	Tertile	IV	0.826	0.284	.034	36	view →
ACC	OS	Tertile	All	0.268	0.802	.010	36	view →
SARC	OS	Tertile	All	0.289	0.741	<.001	36	view →
PAAD	DFS	Tertile	II,III,IV	0.068	0.439	<.001	18	view →
MESO	OS	Tertile	All	0.018	0.559	<.001	18	view →
LUSC	OS	Tertile	II,III,IV	0.250	0.778	.007	18	view →
LGG	OS	Tertile	All	0.957	0.480	.012	12	view →
KIRP	OS	Tertile	All	0.761	0.951	.014	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR4747–THCA (OS)

Open the THCA breakdown →